JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
Amphastar Pharmaceuticals
AMPH
$1.08B
| $5.54M | ﹤0.01% |
295,724
-151,686
| -34% | -$2.85M |
2014 Q3
14 quarters
|
|
2377
CAE Inc
CAE
$7.74B
| $5.54M | ﹤0.01% |
297,869
-328,261
| -52% | -$6.02M |
2014 Q4
13 quarters
|
|
2378
Rogers Corp
ROG
$2.78B
| $5.53M | ﹤0.01% |
46,228
+7,133
| +18% | +$1.08M |
2016 Q2
7 quarters
|
|
|
ASRT
2379
DELISTED
Assertio
ASRT
| $5.52M | ﹤0.01% |
13,952
-2,341
| -14% | -$1.03M |
2015 Q4
9 quarters
|
|
|
MBFI
2380
DELISTED
MB Financial Corp
MBFI
| $5.49M | ﹤0.01% |
135,546
-42,161
| -24% | -$1.82M |
2013 Q2
19 quarters
|
|
|
BPL
2381
CALL
DELISTED
Buckeye Partners, L.P.
BPL
| $5.49M | ﹤0.01% |
+146,700
| New | +$7.13M |
2018 Q1
0 quarters
|
|
2382
LivaNova
LIVN
$4.12B
| $5.48M | ﹤0.01% |
61,908
-122
| -0.2% | -$10.4K |
2015 Q4
9 quarters
|
|
|
RNET
2383
DELISTED
RigNet, Inc.
RNET
| $5.48M | ﹤0.01% |
402,660
-31,717
| -7% | -$487K |
2015 Q4
9 quarters
|
|
2384
Apple Hospitality REIT
APLE
$3.86B
| $5.47M | ﹤0.01% |
311,139
-148,923
| -32% | -$2.73M |
2015 Q4
9 quarters
|
|
2385
Valley National Bancorp
VLY
$7B
| $5.46M | ﹤0.01% |
438,371
-96,802
| -18% | -$1.21M |
2013 Q2
19 quarters
|
|
|
GG
2386
DELISTED
Goldcorp Inc
GG
| $5.46M | ﹤0.01% |
395,006
-1,634,565
| -81% | -$22.1M |
2013 Q2
19 quarters
|
|
2387
Clean Harbors
CLH
$16.5B
| $5.46M | ﹤0.01% |
111,781
-4,565
| -4% | -$239K |
2013 Q2
19 quarters
|
|
|
TLP
2388
DELISTED
Transmontaigne
TLP
| $5.46M | ﹤0.01% |
152,417
+29,941
| +24% | +$1.15M |
2013 Q2
19 quarters
|
|
2389
Cemex
CX
$13.6B
| $5.44M | ﹤0.01% |
822,198
+664,241
| +421% | +$4.97M |
2013 Q2
19 quarters
|
|
2390
Evogene
EVGN
$6.88M
| $5.43M | ﹤0.01% |
32,657
| – | – |
2016 Q1
8 quarters
|
|
|
VRTV
2391
DELISTED
VERITIV CORPORATION
VRTV
| $5.42M | ﹤0.01% |
138,213
-8,917
| -6% | -$271K |
2014 Q3
14 quarters
|
|
|
DCOM
2392
DELISTED
Dime Community Bancshares
DCOM
| $5.42M | ﹤0.01% |
294,400
-24,963
| -8% | -$486K |
2015 Q1
12 quarters
|
|
2393
NACCO Industries
NC
$274M
| $5.42M | ﹤0.01% |
164,833
-9,853
| -6% | -$397K |
2013 Q2
19 quarters
|
|
2394
iShares Europe ETF
IEV
$1.57B
| $5.4M | ﹤0.01% |
115,794
-4,146
| -3% | -$198K |
2015 Q4
9 quarters
|
|
2395
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.21B
| $5.39M | ﹤0.01% |
191,295
-119,191
| -38% | -$3.42M |
2013 Q2
19 quarters
|
|
|
GBT
2396
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.39M | ﹤0.01% |
111,650
-112,229
| -50% | -$6.26M |
2015 Q3
10 quarters
|
|
|
SRCLP
2397
DELISTED
Stericycle, Inc
SRCLP
| $5.39M | ﹤0.01% |
119,121
-42,545
| -26% | -$2.24M |
2015 Q3
10 quarters
|
|
2398
The Ensign Group
ENSG
$9.89B
| $5.39M | ﹤0.01% |
218,968
-12,197
| -5% | -$290K |
2013 Q2
19 quarters
|
|
2399
Ovintiv
OVV
$16.6B
| $5.38M | ﹤0.01% |
97,733
-31,329
| -24% | -$1.86M |
2013 Q2
19 quarters
|
|
|
TWTR
2400
CALL
DELISTED
Twitter, Inc.
TWTR
| $5.37M | ﹤0.01% |
185,000
-309,900
| -63% | -$9.08M |
2014 Q3
14 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.